Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03440996 · ClinicalTrials.gov registry record · NA

Comparison of Three Toothpastes for the Prevention and Reduction of White Spot Lesions

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT03440996: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT03440996 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03440996, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The purpose of the study is to determine if Clinpro™ 5000, Clinpro™ Tooth Crème, or MI-Paste Plus has an effect on the formation and resolution of white spot lesions for patients undergoing orthodontic treatment. This study will include 90 patients in the UAB Orthodontic Clinic.

Primary Outcome

Photographic records will be used to determine the improvements in the white spot lesions. A standard intra-oral photographic camera will be utilized and the photographs will be taken in a light controlled environment and photographs will be captured in a pre-set photographic protocol. The Enamel decalcification index (EDI) will be used to determine the number of white spot lesions present at each time frame.

Interventions

  • OTHER Clinpro™ 5000
  • OTHER Clinpro™ Tooth Crème
  • OTHER MI-Paste Plus

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2011-01-14
Est. Completion 2011-12-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT03440996 record still lists

NCT03440996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 3 interventions - of which Clinpro™ 5000 is the first listed.

NCT03440996 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03440996 about?

NCT03440996 is a clinical study titled "Comparison of Three Toothpastes for the Prevention and Reduction of White Spot Lesions". The purpose of the study is to determine if Clinpro™ 5000, Clinpro™ Tooth Crème, or MI-Paste Plus has an effect on the formation and resolution of white spot lesions for patients undergoing orthodontic treatment. This study will include 90 patients in the UAB Orthodontic Clinic.

What is the current status of trial NCT03440996?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-01-14. Estimated completion is 2011-12-30.

What interventions are being tested in trial NCT03440996?

The interventions under investigation include: Clinpro™ 5000 (OTHER), Clinpro™ Tooth Crème (OTHER), MI-Paste Plus (OTHER).

Who is sponsoring clinical trial NCT03440996?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03440996's enrollment target sits among peer trials

90 941st of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03440996, the US trial registry maintained by the National Library of Medicine. NCT03440996 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.